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Abstract  
The coronavirus pandemic has upended modern society and forced governments in countries around the 
world to reevaluate their current healthcare systems. This study attempts to understand the relationship 
between a country’s healthcare capabilities (as measured by current health expenditure) and their 
response to the coronavirus pandemic (as measured by COVID-19 cases). Other explanatory variables in 
this study are HDI indexes, life expectancy, GDP per capita and COVID-19 deaths will be used to further 
understand the relationship. This study uses simple and multiple regression models to estimate the 
relationship between current health expenditure and COVID-19 cases. A positive correlation between 
health expenditure and COVID-19 cases is hypothesized and supported by the linear regression models 
constructed in this study.  
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I. Introduction  
The COVID-19 pandemic has impacted the entire world, and as time moves on, reflections on the 
preparedness of countries, and preparations for the next pandemic will need to take place. It is key to 
understanding the current response to the COVID-19 pandemic in order to develop a relationship between 
specific factors that have led to different outcomes in countries with similar levels of preparedness. 
Understanding the relationship between health expenditure as a percent of GDP and the number of 
COVID-19 cases in a country will be a good indicator of the relationship between a country’s healthcare 
capabilities and it’s COVID-19 response.   
 
The definition of current health expenditure is spending on healthcare goods and services, expressed as a 
percentage of GDP. It excludes capital health expenditures such as buildings, machinery, information 
technology and stocks of vaccines for emergency or outbreaks. This metric was invented as a way to 
measure the progress of the United Nation’s (UN) Sustainable Development Goal (SDG) three (good 
health and well-being). This specifically deals with subgoal SDG 3.C which the mission statement is to 
substantially increase health financing and the recruitment, development, training and retention of the 
health workforce in developing countries, especially in least developed countries and small island 
developing States.  
 
This analysis of COVID-19 cases and current health expenditure will be beneficial to not only trying to 
complete the UN’s Sustainable development goals, but to be better prepared for the next pandemic. 
Understanding the impact of current health expenditure will be beneficial for all countries, as health is 
also one of the main factors of the Human Development Index (HDI), which is the ultimate criteria for 
assessing the development of a country. People who live in high HDI ranked countries tend to be happier, 
healthier, more educated and have a higher standard of living. Improving one aspect will lead to increases 
in other dimensions of HDI.  
 
This study will utilize cross-sectional data from a variety of sources to create several different simple and 
multiple regression models. The hypothesis is that as health expenditure in a country increases, the 
COVID-19 cases in that country will also increase. The rationale behind this is as countries spend more 
money on healthcare goods and services and therefore improve their healthcare infrastructure the 
availability and ease of testing will lead to higher COVID-19 cases. There are speculation that actual 
COVID-19 cases are much higher than confirmed COVID-19 cases in just about every country in the 
world. So, as countries can test more of their population, they will also reveal more positive COVID-19 
cases.  
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II. Literature Review  
To study the effect of public health expenditure on COVID-19 Khan, Awan, Islam and Muurlink (2020) 
used data from the Johns Hopkins University database, World Bank records and the National Civic Space 
Ratings 2020 database. They created a regression model that was used to assess the association between 
case fatality (a ratio of total number of confirmed deaths to total number of confirmed cases) and 
healthcare capacity index adjusting for other omitted variables. The regression analysis shows that greater 
healthcare capacity was related to lesser case-fatality with every additional unit increase in the healthcare 
capacity index associated with a 42% decrease in the case fatality. The paper did address health 
expenditure, but the variable did not reach statistical significance, even though it was negatively 
correlated with case fatalities. The research suggests that building effective multidimensional healthcare 
capacity is the most promising means to mitigate future case fatalities. The data also suggests that 
government's ability to implement public health measures determines mortality outcomes. Therefore, this 
paper reached the conclusion that as public health spending increases, the mortality rate of public health 
crises will drop.  
 
Eissa (2020) completed research and analyzed global health spending patterns pre- and post-COVID-19. 
They also analyzed country specific case studies and proposed policy recommendations. The study 
focused on different scenarios for restructuring public health spending to build preparedness and 
resilience in healthcare systems for pandemic and public health crises. This paper raises awareness for the 
importance of formulating pandemic preparedness and executing it in all three stages of the pandemic 
before, during and after. Public health expenditure, a part of pandemic preparedness, along with efficient 
healthcare systems, plus traditional factors which includes the time element of quick response to the 
pandemic, are measures of sustainable health. Investment in national healthcare ensures efficient resource 
allocation. The policy recommendations call for restructuring public expenditure to expand the absorptive 
capacity of healthcare institutions, eventually leading to sustainability and universal health insurance. 
This paper did not have regression models, but instead drew conclusions from simple correlation models 
that dealt with public health expenditure in specific countries. Eissa (2020) formed conclusions through 
researching SDGs and understanding public health spending patterns. They came to the conclusion that a 
universal health insurance would be able to restructure and expand healthcare capacity. In relation to 
COVID-19 this would mean that there would be a lower mortality rate as spending on public health 





Stribling, Clifton, McGill and Vries (2020) completed a cross-sectional data analysis with the top 36 
countries, as ranked by the Global Health Security Index scores. This security index ranks countries based 
on their health security capabilities which includes their preparedness for an infectious disease outbreak 
or any other public health crises. This index provided data about each nation's expenditure on health and 
the nursing workforce, and Stribling, Clifton, McGill and Vries (2020) compared these with mortality 
data for COVID‐19. They reached the conclusion that the extent of a country's pandemic preparedness, 
magnitude of the nursing workforce and public healthcare expenditure did not significantly impact a 
nations COVID-19 mortality rate. This can be seen as an unexpected result, because the other two papers 
found that increasing public health expenditure alone would lead to a sharp decrease in mortality rate. 
Stribling, Clifton, McGill and Vries (2020) also reached the conclusion that this was something of a 
paradox. Their conclusion was that arrangements for dealing with future public health crises must involve 
a range of experts in the field of public health and agencies that can coordinate a response. This paper 
found that coordination was key in developing an appropriate response to the COVID-19 pandemic, as 
and preparedness may not matter if not coordinated effectively.  
 
There is a lot of research analyzing the impact of public health expenditure on pandemics, however this 
study will provide a different perspective on the topic. This paper is focusing on how COVID cases can 
be impacted by spending on the healthcare expenditure. There will be a main focus on one dependent 
variable of the natural logarithm of COVID-19 cases from 171 different countries. This dependent 
variable will go through regression models with up to four different explanatory variables that will help to 
understand the impact of public health expenditure on COVID cases. Much of the previous research was 
focused on mortality rate or pandemic preparedness, this paper will focus on how COVID-19 cases in 
general have a relationship with the Human Development Index, health expenditure, GDP per capita, 
COVID deaths and life expectancy. For these reasons this study should provide a clearer understanding 











III. Data  
To understand the relationship between current health expenditure and COVID-19 cases, cross-sectional 
data for around 171 countries was found. The data for the dependent variable, total COVID-19 cases by 
country was then changed to a natural logarithm of those values to prevent outliers from skewing the data. 
The data for COVID-19 cases was sourced from the World Health Organization and is continuing to be 
updated every day. Currently the data used in this study is from March 2021. The primary explanatory 
variable is current health expenditure as a percentage of Gross Domestic Product (GDP). This data was 
sourced from the World Bank in 2017. Current health expenditure as a percent of GDP was picked instead 
of total amount spent on health expenditure in US dollars, as the percent of GDP creates an equal 
opportunity for all countries to have high percentages spent on healthcare goods and services. This is 
because richer countries would just be able to spend more money on healthcare even if it is a lower 
percentage of the GDP, current health expenditure can also give an insight as to how important a country 
views its own healthcare system. An initial scatter plot of the natural logarithm of COVID cases and 
current health expenditure as a percent of GDP shows a positive, but mild correlation between the two 
variables. This scatter plot can be seen below in Figure 1.  
Figure 1 – Scatterplot of logCOVIDcases vs HealthExp 
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In addition to the primary explanatory variable of current health expenditure as a percent of GDP, there 
are three other secondary explanatory variables for the dependent variable of COVID cases, as well as 
another dependent variable of the natural logarithm of COVID deaths. These other variables include 
Human Development Index (HDI) values, life expectancy and the natural logarithm of GDP per capita. 
The data for the HDI values was sourced from the World Bank and was created in 2019. The HDI is a 
summary index that measures, achievement in three dimensions of human development: a long and 
healthy life, being knowledgeable, and having a decent standard of living. The HDI is a score from zero 
to one and the countries with higher scores have higher levels of human development. Because of the 
dimensions the HDI value covers it should be predicted in the regression models to have a positive 
coefficient when regressed with COVID cases. This is because as a countries HDI increases the 
healthcare system of a country should be well funded and equipped to test a large percentage of the 
population, which can lead to a higher number of COVID-19 cases.  The data on life expectancy was 
sourced from the UNDESA and the data was obtained in 2017. Life expectancy measures the average 
period a person in a country will live in years. The data for GDP per capita was obtained from the World 
Bank and is from 2019. GDP per capita is in the units of 2017’s Purchase Power Parity in US Dollars. 
This data was also changed to a logarithm form to prevent skewing of the data by potential outliers. The 
data for the second dependent variable, total COVID-19 deaths per country was sourced from the World 
Health Organization. The data was also obtained in March 2021, and this data was also converted to a 
logarithm form. A summary of each variable can be found below in Table 1. 
Table 1 – Variable Descriptions 
Variable Name Description Year Units Source 
HealthExp Current Health Expenditure 2017 Percentage of 
GDP 
World Bank 
HDIindex Human Development Index  2019 Indices World Bank 
LifeExp Life Expectancy at Birth 2017 Years UNDESA 
logCOVIDcases Natural Logarithm of 
COVID-19 Cases 
2021 Number of People WHO 
logCOVIDdeaths Natural Logarithm of 
COVID-19 Deaths 
2021 Number of People WHO 
logGDPcap Natural Logarithm of GDP 
per capita 





Descriptive statistics for each variable can be found below in Table 2. 
Table 2 – Variable Descriptive Statistics 
Variable Observations Mean Std. Dev. Min. Max. 
HealthExp 171 6.48 2.56 1.20 17.10 
HDIindex 169 0.72 0.15 0.40 0.96 
LifeExp 171 72.21 7.80 52.20 84.30 
logCOVIDcases 171 4.84 1.05 1.83 7.47 
logCOVIDdeaths 171 3.03 1.18 0 5.73 
logGDPcap 166 4.09 0.51 2.88 5.06 
 
Data on HDI values, health expenditure, life expectancy, GDP per capita, COVID cases and COVID 
deaths were sourced from 171 countries. Country names can be found in Appendix A. The sample sizes in 
each model remained relatively consistent as each variable apart from HDI values and GDP per capita had 
171 observations.  
Before creating the regression models the Gauss Markov assumptions have to be checked in order to have 
the best linear unbiased estimate possible. The five Gauss Markov assumptions and the normality 
assumption for the Classic Linear Model can be seen below. 
Gauss Markov and Classic Linear Model Assumptions: 
1. Linearity: Model is linear in parameters so that y = B₀ + B₁X₁ + B₂X₂ + ... + BnXn + u, Where B 
coefficients are the unknown parameters and u is the error term. All models in Section IV. of the 
paper satisfy this assumption as the coefficients are linear in parameters, with a u error term. 
2. Random: Data sourced from random sampling; the data was sourced from countries around the 
world. There was no deliberation for the countries in the sample. So, this proves that the sampling 
was random. 
3. Non-Collinearity: The explanatory variables are not perfectly correlated to each other. STATA 
has commands to check the collinearity between the variables. The results of the STATA output 
showed that the variables are not perfectly correlated. The specific values can be found in 
Appendix B. 
4. Exogeneity: Zero conditional mean, this means the expected value of the error term, u, is zero 
given any value for any of the explanatory variables. It is difficult to make sure that the error term 
is not correlated to COVID cases as the amount of COVID cases could be influenced by other 
factors not taken into consideration in this study. So, close consideration of the results must be 
maintained.  
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5. Homoskedasticity: The variance of the error term, u, has a constant variance given any value of 
an explanatory variable. It is also difficult to make sure the error term variance remains constant 
as omitted variables may shift or influence the variance of the error term. Again, close 
consideration of the results must be maintained.       
6. Normality: The population error u is independent of the explanatory variables and is normally 
distributed with zero mean and variance. While this assumption may not be completely fulfilled 
because for some of the variable’s normality may not be a good assumption. Regardless this 
assumption cannot be fully verified in this study therefore close consideration of the results will 
be maintained.  
 
IV. Results  
With the Gauss Markov and Classic Linear Model assumptions being fulfilled, STATA has now been 
used to compute regression models that can test the hypothesis. All STATA regression outputs can be 
found in Appendix C.  
 
Model 1:  
Model 1 is a simple regression model that is designed to test the relationship between the dependent 
variable natural logarithm of COVID cases and the primary explanatory variable current health 
expenditure.  
Model 1: logCOVIDcases = B0 + B1(HealthExp) + u 
This model has 171 countries. From the STATA output the estimated equation can be written as: 
Estimated Equation 1: logCOVIDcases = 3.99 + 0.13(HealthExp) 
This model has an R-squared value of 0.10, denoting a weak correlation between health expenditure and 
COVID-19 cases. The coefficient of health expenditure is positive denoting a positive linear relationship 
which was predicted. Since a log-level model was created this coefficient can be interpreted to describe 
that a 1% increase in health expenditure will lead to a 13% increase in COVID-19 cases. This simple 
regression model shows a positive relationship between health expenditure and COVID cases, which 
currently proves the hypothesis to be correct. Health expenditure is significant at the 1% level.  
This simple linear regression model provides a good starting point for testing and understanding the 
relationship between COVID cases and health expenditure. But there is still a possible omitted variable 
bias, and to reduce that bias multiple explanatory variables need to be used in a multiple linear regression. 
Holding added explanatory variables fixed will lead to a better understanding of the ceteris paribus 
relationship between COVID cases and health expenditure. 
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Model 2:  
Model 2 is a multiple regression model that was created using all the explanatory variables which now 
includes GDP per capita, health expenditure, HDI values and life expectancy. 
Model 2: logCOVIDcases = B0 + B1(HealthExp) + B2(HDIindex) + B3(LifeExp) + B4(logGDPcap) + u 
This model has 165 countries. From the STATA output the estimated equation can be written as: 
Estimated Equation 2: logCOVIDcases = 2.09 + 0.06(HealthExp) + 3.06(HDIindex) + 0.03(LifeExp) -
0.45(logGDPcap) 
This model has an R-squared value of 0.27, indicating a low/mild correlation between the explanatory 
variables and the dependent variable. This model has the greatest number of explanatory variables leading 
to the highest R-squared value amongst all the models. Because of the omitted variable bias that is present 
in Model 1 the value for HealthExp in this model has decreased as compared to the value in Model 1. The 
omitted variable bias will overestimate the impact of health expenditure on COVID cases. The coefficient 
of health expenditure is still positive but indicates a 1% increase in health expenditure leads to only an 6% 
increase in COVID cases. HDI index also has a positive coefficient, indicating a positive relationship 
between HDI values and COVID cases. The result can be interpreted as every 0.01 increase in the HDI 
value will lead to a 3.06% increase in COVID cases. The most surprising variable from the regression is 
GDP per capita because it has a negative coefficient indicating a negative relationship with COVID cases. 
The result can be interpreted as every 1% increase in GDP per capita leads to a 0.45% decrease in COVID 
cases. This is the first variable to have a negative relationship with COVID cases, and it indicates that 
richer countries with higher GDP per capita will also have fewer COVID cases. All the variables are at 
least significant at the 10% level except for the logarithm of GDP per capita.  
 
Model 3:  
Model 3 is a multiple regression model that includes the HDI index variable, health expenditure and GDP 
per capita. Life Expectancy was dropped from this model because of its low statistical significance at the 
10% level and the low coefficient of the variable in Model 2.  
Model 3: logCOVIDcases = B0 + B1(HealthExp) + B2(HDIindex) + B3(logGDPcap) + u 
This model has 165 countries. From the STATA output the estimated equation can be written as: 
Estimated Equation 3: logCOVIDcases = 3.25 + 0.07(HealthExp) + 4.17(HDIindex) – 
0.46(logGDPcap) 
This model has an R-squared value of 0.26 still indicating a relatively weak correlation between COVID 
cases and health expenditure. All the coefficients are relatively the same except for HDI index, this could 
be caused by the relatively high correlation between HDI index and life expectancy, therefore leading to 
the regression estimating HDI index is the most significant variable at understanding total COVID cases 
 10 
by country. The new coefficient of HDI index can be interpreted as every 0.01 increase in the HDI value 
can lead to a 4.17% increase in COVID cases. The regression output is still showing that GDP per capita 
and COVID cases have a negative relationship. This output is indicating that a higher HDI score leads to 
more COVID cases, even though GDP per capita is a part of one of the dimensions that are included in 
HDI values. This just shows that countries may have a high GDP per capita, and will not allocate 
resources to healthcare spending or other dimensions of the HDI value. These countries could have higher 
levels of corruption, income inequality or may have different priorities when allocating government 
spending. HDI index is significant at the 1% level, health expenditure is significant at the 5% level, but 
GDP per capita is still not significant at the 10% level.  
 
Model 4:  
Model 4 is a multiple regression model that includes health expenditure and GDP per capita. It was 
already established that HDI index is statistically significant and has a large positive coefficient for 
COVID cases, but the relationship between COVID cases and GDP per capita could still be better 
understood. Therefore, HDI index values were dropped from this model.  
Model 4: logCOVIDcases = B0 + B1(HealthExp) + B2(logGDPcap) + u 
This model has 166 countries. From the STATA output the estimated equation can be written as: 
Estimated Equation 4: logCOVIDcases = 1.50 + 0.10(HealthExp) + 0.66(logGDPcap) 
This model has an R-squared value of 0.20, which is still a weak correlation. The coefficient of health 
expenditure increased this could be due to this regression having fewer explanatory variables as compared 
to Model 2 and Model 3. The regression again overestimates the importance of health expenditure as a 
variable for COVID cases. The new value can be interpreted as a 1% increase in health expenditure leads 
to a 10% increase in COVID cases. The most surprising outcome of this regression is that GDP per capita 
now has a positive coefficient, and the coefficient can be interpreted as a 1% increase in GDP per capita 
leads to a 0.66% increase in COVID cases. Without the variable of HDI index the regression output could 
have overestimated the relationship between COVID cases and GDP per capita. Not only did the 
coefficient become positive but the statistical significance of the variable increased to be significant at the 
1% level. The variable of health expenditure was also significant at the 1% level.  
 
Model 5:  
Model 5 is another simple regression model that is designed to test the relationship between the dependent 
variable natural logarithm of COVID deaths and the primary explanatory variable current health 
expenditure. This regression is meant to see if as health expenditure increases this will lead to an increase 
or decrease in COVID related deaths.  
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Model 5: logCOVIDdeaths = B0 + B1(HealthExp) + u 
This model has 171 countries. From the STATA output the estimated equation can be written as: 
Estimated Equation 5: logCOVIDdeaths = 1.97 + 0.16(HealthExp) 
Model 5 has an R-squared value of 0.12 this is the second lowest R-squared value of the five regression 
models. The coefficient of current health expenditure is positive, meaning that as expenditure increases 
COVID deaths will also increase. This was not a predicted outcome as the literature review concluded 
that as health expenditure increased the mortality of COVID-19 should decrease. But this could also be 
because we are not looking at COVID deaths in relation to the population or number of COVID cases, if 
these other variables were to be considered health expenditure could have a different relationship with 
COVID deaths. The high correlation between COVID deaths and COVID cases can be the cause of the 
very similar relationship the two dependent variables have with the explanatory variable of health 
expenditure. Currently a 1% increase in health expenditure leads to an 16% increase in COVID deaths. 
Health expenditure is significant at the 1% level in this model.  
 
A summary of all five regression models can be seen in Table 3. 
Table 3 – Regression Models Summary 
Dependent Variable: logCOVIDcases Dependent Variable: 
logCOVIDdeaths 
















LifeExp  0.03* 
(0.02) 
   

















No. of Observations 171 165 165 166 171 
R-squared 0.10 0.27 0.26 0.20 0.12 





After Model 1 and Model 2 were analyzed and individual significance levels were found, it became 
important to use an F-test to understand the significance of all the secondary explanatory variables. This 
includes HDI index, life expectancy and GDP per capita. All the variables are included in Model 2 to 
create an unrestricted regression, and Model 1 would be used as a restricted regression. Therefore, the 
hypothesis for Model 2 can be seen below: 
H0: B2 = 0, B3 = 0, B4 = 0 
H1: H0 is false 
An F-value of 11.67 was calculated using STATA’s F-test commands. At the 1% significance level for F 
(3,160) the critical value is 3.78. Since the calculated F-value is greater than the critical F-distribution value. 
The null hypothesis is rejected; therefore, all the variables are jointly significant at the 1% level. This 
reaffirms the significance level found in the Results Section. This also shows that GDP per capita is 
statistically significant, even though individually it was not significant at the 10% level. This shows that 
the data selected can lead to reliable conclusions on the topic because of the high statistically significant 
levels.  
 
The F-test will be completed again with Model 2 as the unrestricted model, but now with Model 4 as the 
restricted model. Therefore, HDI values and life expectancy will be the variables being tested for joint 
significance. The hypothesis for Model 2 can be seen below:  
H0: B2 = 0, B3 = 0 
H1: H0 is false 
An F-value of 6.18 was once again found using STATA’s F-test commands. The critical value of the F 
distribution at the 1% level for F (2,160) is 4.61. Just like the previous F-test the critical value is smaller 
than the calculated F-value, therefore the variables are jointly significant at the 1% level. The null 
hypothesis is rejected because the variables are jointly significant. With the results of the two F-tests it 
can be concluded that the three secondary explanatory variables are statistically significant in the models, 
and therefore have major significance in the results.  
 
After analyzing the correlation and mild positive relationship between COVID cases and the current 
health expenditure of a country it was decided it would be appropriate to test a different functional form 
as compared to the models tested in the Results Section. Based off the relationship shown in the initial 
scatter plot of the logarithm of COVID cases and the health expenditure of a country, the line of best fit 
may be better estimated as a natural logarithm as compared to a linear function. So, a new explanatory 
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variable of the natural logarithm of health expenditure (logHealthExp) was created and was added to the 
simple regression of Model 1, to construct Model 6.  
Model 6: logCOVIDcases = B0 + B1(HealthExp) + B2(logHealthExp) + u 
This model has 171 countries included in it. The assumptions needed for an unbiased regression output 
have been met, but the correlation coefficient between the logarithm of health expenditure and health 
expenditure is 0.96, which is a very high value. This means results need to be analyzed with the 
consideration of near multicollinearity. 
From the STATA output the estimated equation can be written as: 
Estimated Equation 6: logCOVIDcases = 4.26 + 0.16(HealthExp) + -0.82(logHealthExp) 
Model 6 has an R-squared value of 0.10 indicating a very weak relationship between the explanatory and 
dependent variables. This is the same R-squared value that Model 1 has, showing that there has not been 
any significant change by adding the logarithm of health expenditure to the model. In this model 
HealthExp is significant at the 10% level, whereas the new variable logHealthExp is insignificant at the 
10% level. In Model 1 HealthExp was significant at the 1% level showing a big drop in significance 




The hypothesis of a positive correlation between health expenditure and COVID-19 cases was proven to 
be true by the regression models. Unfortunately, the regression models also had relatively low R-squared 
values leading to the conclusion that there was a relatively weak positive correlation between current 
health expenditure and total COVID-19 cases by country. Increasing healthcare expenditure in a country 
has led to the discovery of more COVID-19 cases, this is not a negative, as learning more about the virus 
and testing more of the population is required to find solutions to this public health crisis. Increasing 
current health expenditure will also lead to better preparedness for the next global pandemic. Increasing 
current health expenditure can also lead to more countries meeting SDG three, which leads to healthier 
humans around the world. 
All the secondary explanatory variables proved to be statistically significant, and therefore verified that 
the regressions created reliable outputs. GDP per capita, HDI values and life expectancy were all jointly 
significant after going through the F-test, and each had very different relationships with the dependent 
variable of COVID cases. It was very peculiar to see the relationship between GDPs per capita and 
COVID cases flip from a negative relationship Model 2 and Model 3 to a positive relationship in Model 
4. There was also Model 5 where a different dependent variable of COVID deaths was used in a simple 
regression model with current health expenditure. That model also showed a positive correlation between 
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health expenditure and COVID deaths, but that was to be expected after seeing the high correlation 
between COVID deaths and COVID cases.  
Acquiring new secondary explanatory or secondary dependent variables to extend the models created in 
this study will be critical to understand more relationships of different variables in the COVID-19 
pandemic. In the future, there could be time lags between the explanatory variables and the dependent 
variables to understand the complete impact of health expenditure on the COVID-19 pandemic. As it 
takes time for healthcare systems to modernize or for new medical supplies to be shipped around the 
world. Currently, this data can help countries around the world make informed decisions regarding their 
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Appendix B. Correlation Coefficients, Gauss Markov Assumption 3 
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